Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis

NCT03046251 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Natalizumab

Sponsor

State University of New York at Buffalo